E0 ConsensusModerate confidencePEM unclearEvidence-MapPeer-reviewedMachine draft
Frontiers in chronic fatigue syndrome research: An analysis of the top 100 most influential articles in the field.
Wang, Xingxin, Li, Xuhao, Dong, Tiantian et al. · Medicine · 2023 · DOI
Quick Summary
This study analyzed the 100 most-cited scientific papers on ME/CFS to understand what researchers have been focusing on and what directions the field is moving toward. Researchers found that ME/CFS research is a global effort involving hundreds of institutions across many countries, with studies increasingly looking at cognitive behavioral therapy, how to diagnose ME/CFS better, and the biological basis of the condition. The analysis suggests future research will likely focus on finding biological markers, understanding immune system changes, and identifying genetic risk factors.
Why It Matters
This comprehensive landscape analysis provides patients and researchers with a clear picture of where ME/CFS research has concentrated and where it is heading, helping guide future investigations and resource allocation. By identifying emerging research trends in biomarkers, immunology, genetic screening, and epidemiology, it offers hope that future studies may lead to improved diagnostic tools and biological understanding of the disease.
Observed Findings
- The top 100 most-cited ME/CFS articles were published across 67 journals with The Lancet showing the highest publication volume and citation count.
- 250 institutions across 26 countries/regions contributed to the top 100 most-cited publications, demonstrating global research engagement.
- The five most frequently co-occurring keywords were chronic fatigue syndrome, cognitive behavior therapy, epidemiology, definition, and disorders.
- Cluster analysis identified primary care, infectious retrovirus, gene expression, and metabolomics as emerging focal areas in CFS research.
- Research themes suggest future directions include search for biological markers (especially immunological), advancement of diagnostic techniques, screening for risk genes, and epidemiological investigation.
Inferred Conclusions
- ME/CFS research is characterized by interdisciplinary and multidisciplinary approaches with substantial international collaboration.
- Diagnosis and case definition remain central concerns in the field, alongside investigation of cognitive and behavioral interventions.
- Future ME/CFS research is likely to shift toward biomarker discovery, particularly in immunology and gene expression, rather than relying solely on clinical and behavioral approaches.
Remaining Questions
- Which of the identified emerging areas (immunology, metabolomics, gene expression, infectious retroviruses) will yield the most clinically useful biomarkers?
What This Study Does Not Prove
This study is a bibliometric analysis (a 'map' of existing literature) and does not itself prove or test any treatment, biological mechanism, or diagnostic criterion. It does not evaluate the quality or validity of the papers it analyzed, nor does it establish which research findings are clinically significant or reproducible. The prominence of cognitive behavioral therapy in the top-cited papers does not necessarily indicate it is an effective treatment for all ME/CFS patients.
Tags
Symptom:Cognitive DysfunctionFatigue
Biomarker:CytokinesMetabolomicsGene Expression
Phenotype:Infection-Triggered
Method Flag:Exploratory Only
Metadata
- DOI
- 10.1097/MD.0000000000035754
- PMID
- 37986358
- Review status
- Machine draft
- Evidence level
- Established evidence from major reviews, guidelines, or evidence maps
- Last updated
- 8 April 2026
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →